Evidence map›Paper›PMID 31827776›Full record

ArticleAntimicrobial resistance and infection control2019

Colonisation with pathogenic drug-resistant bacteria and

Jason September, Leon Geffen, Kathryn Manning, Preneshni Naicker, Cheryl Faro, Marc Mendelson, Sean Wasserman

Open access · goldAbstract read
In one paragraph

Article in Antimicrobial resistance and infection control, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Jason September1Department of Medicine, University of Cape Town, Cape Town, South Africa.
Leon Geffen2Samson Institute for Ageing Research. Institute of Ageing in Africa, University of Cape Town, Cape Town, South Africa.
Kathryn Manning1Department of Medicine, University of Cape Town, Cape Town, South Africa.
Preneshni Naicker3Division of Medical Microbiology, University of Cape Town, Cape Town, South Africa.
Cheryl Faro1Department of Medicine, University of Cape Town, Cape Town, South Africa.
Marc Mendelson1Department of Medicine, University of Cape Town, Cape Town, South Africa.
Sean Wasserman1Department of Medicine, University of Cape Town, Cape Town, South Africa.ORCID 0000-0002-3508-6719
University of Cape Town · ZADesmond Tutu HIV Foundation · ZA

Funding

Wellcome Trust 203135/Z/16/Z
6 · The paper itself

Abstract

Background: Residential care facilities (RCFs) act as reservoirs for multidrug-resistant organisms (MDRO). There are scarce data on colonisation with MDROs in Africa. We aimed to determine the prevalence of MDROs and Methods: We performed a cross-sectional surveillance study at three RCFs. Chromogenic agar was used to screen skin swabs for methicillin-resistant Results: One hundred fifty-four residents were enrolled, providing 119 stool samples and 152 sets of skin swabs. Twenty-seven (22.7%) stool samples were positive for ESBL-E, and 13 (8.6%) residents had at least one skin swab positive for MRSA. Two (1.6%) stool samples tested positive for Conclusions: There was a relatively high prevalence of colonisation with MDROs, particularly ESBL-E, but low

Indexed as

Drug Resistance, Multiple, BacterialAgedAged, 80 and overBacterial InfectionsCarrier StateClostridioides difficileCross-Sectional StudiesDisease ReservoirsEnterobacteriaceaeEnterobacteriaceae InfectionsFecesFemaleHumansMaleMethicillin-Resistant Staphylococcus aureusPrevalenceAntibiotic resistanceAntibiotic stewardshipC. difficileColonizationESBLInfection controlMRSAResidential care facility

Identifiers

PMID31827776
PMCPMC6862804
OpenAlexW2990503589

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.